<DOC>
	<DOCNO>NCT02695771</DOCNO>
	<brief_summary>To compare efficacy Mitomycin C vs. Gemcitabine vs. adjuvant treatment single intraoperative instillation prevent recurrence bladder cancer .</brief_summary>
	<brief_title>The Bladder Instillation Comparison Study</brief_title>
	<detailed_description>This study compare standard care treatment patient non-muscle invasive bladder cancer ( NMIBC ) . Patients randomize one three arm , Mitomycin C , Gemcitabine additional treatment immediately follow TURBT operate suite . All treatment , surgical procedure follow care conduct accord standard care treatment .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>1. sign inform consent study 2. schedule TURBT suspect nonmuscle invasive bladder tumor . 1. patient unable consent 2. individual 18 year old 3. pregnant woman 4. prisoner 5. patient know allergy intolerance mitomycin C Gemcitabine 6. sound medical , psychiatric and/or social reason determine investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>bladder tumor</keyword>
	<keyword>urinary tumor</keyword>
	<keyword>non-muscle invasive bladder tumor</keyword>
	<keyword>NMIBC</keyword>
</DOC>